Ibu and Full blood count abnormal - a phase IV clinical study of FDA data

Summary:

Full blood count abnormal is reported as a side effect among people who take Ibu (ibuprofen), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Jakafi, and have Primary myelofibrosis.

The phase IV clinical study analyzes which people have Full blood count abnormal when taking Ibu. It is created by eHealthMe based on reports of 240,078 people who have side effects when taking Ibu from the FDA, and is updated regularly.

What is Ibu?

Ibu has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 246,531 Ibu users. Check the latest studies of Ibu.

What is Full blood count abnormal?

Full blood count abnormal is found to be associated with 630 drugs and 378 conditions by eHealthMe. Check the latest studies of Full blood count abnormal.

On Jul, 24, 2026

240,078 people reported to have side effects when taking Ibu.
Among them, 87 people (0.04%) have Full blood count abnormal.

Could Ibu cause Full blood count abnormal?

Among these 87 people:

How long have people been on Ibu when they have Full blood count abnormal? *

What is the gender of people who have Full blood count abnormal when taking Ibu? *

female: 83.33 %
male: 16.67 %

What is the age of people who have Full blood count abnormal when taking Ibu? *

What are other drugs people take besides Ibu? *

What are other side effects people have besides Full blood count abnormal? *

Fatigue (feeling of tiredness): 38 people, 43.68%
Nausea (feeling of having an urge to vomit): 19 people, 21.84%
Weakness: 15 people, 17.24%
Weight Increased: 14 people, 16.09%
White Blood Cell Count Decreased: 14 people, 16.09%
Constipation: 14 people, 16.09%
Thrombocytopenia (decrease of platelets in blood): 12 people, 13.79%
Rashes (redness): 12 people, 13.79%
Abdominal Discomfort: 11 people, 12.64%
Dizziness: 11 people, 12.64%

What are the existing conditions these people have? *

Primary Myelofibrosis (primary disorder of the bone marrow): 10 people, 11.49%
Ovarian Cancer (cancer of ovary): 7 people, 8.05%
Breast Cancer Female: 6 people, 6.90%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 6.90%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 4 people, 4.60%
High Blood Pressure: 4 people, 4.60%
Quit Smoking: 4 people, 4.60%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 3.45%
Asthma: 3 people, 3.45%
Indigestion: 3 people, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Ibu and have Full blood count abnormal?

- Check whether Full blood count abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ibu:

Ibu (246,531 reports)

Browse all side effects of Ibu:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Full blood count abnormal:

Full blood count abnormal (630 drugs)

Browse all the conditions that are associated with Full blood count abnormal:

Full blood count abnormal (378 conditions)

Related publications that referenced our studies

Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on ibuprofen (the active ingredients of Ibu) and Ibu (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.